Medicamen Biotech Fundamental Analysis
MEDICAMEQ
318.63.15 (-0.98%)
Last updated on 1 Oct, 2026 | 15:31 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Medicamen Biotech Fundamentals
P/E Ratio
39.49
P/B Ratio
1.58
Div. Yield
0.32
Sector P/E
42.73
Sector P/B
3.57
Sec. Div. Yield
0.51
Medicamen Biotech Fundamentals is currently trading with a P/E Ratio of 39.49, compared to the sector average of 42.73. Its P/B Ratio stands at 1.58, while the sector’s is 3.57. In terms of returns, the stock offers a Dividend Yield of 0.32%, which is than the sector’s 0.51%.
Medicamen Biotech Score Card
Price
Attractive
Growth
Poor
Quality
Poor
Management
Average
On its scorecard, Medicamen Biotech reflects: Price – Attractive, Growth – Poor, Quality – Poor, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in MEDICAMEQ
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC